Literature DB >> 6158439

Specific and non-specific multiple unit activities during pentylenetetrazol seizures. I. Animals with 'encéphale isolé'.

F Velasco, M Velasco, R Romo.   

Abstract

The present report describes the sequence of activation and deactivation of multiple unit activities (MUA) in the brain stem reticular formation and pyramidal tract, in relation to the clinical seizure and electroencephalographic and electromyographic tonic-clonic discharges induced by pentylenetetrazol (PTZ), in cats immobilized by high spinal transection ('encéphale isolé'). Threshold doses of PTZ (20 mg/kg i.v.) produced the following events: (1) Significant increase in mesencephalic and pontine MUA, anticipating 2 (+/- 1) sec the clinical and electromyographic seizures and 5 (+/- 2) sec the onset of EEG and pyramidal tract tonic-clonic discharges. (2) A further increase in mesencephalic and pontine reticular MUA and electromyogram MUA at the onset of EEG and pyramidal tract tonic-clonic discharges. (3) Significant decrease of EEG spike activity and pyramidal tract MUA to levels below the control period 16 (+/- 8) sec later, while mesencephalic and pontine MUA and electromyogram remained very high. Results suggest that (i) PTZ-induced seizures start in the brain stem reticular formation and propagate to muscles by at least two different pathways: a pyramidal and an extrapyramidal pathway; (ii) that inhibition of seizure activity may start at the cortical level.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158439     DOI: 10.1016/0013-4694(80)90400-9

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  1 in total

1.  Anticonvulsant and antioxidant effects of Tilia americana var. mexicana and flavonoids constituents in the pentylenetetrazole-induced seizures.

Authors:  Noemí Cárdenas-Rodríguez; María Eva González-Trujano; Eva Aguirre-Hernández; Matilde Ruíz-García; Aristides Sampieri; Elvia Coballase-Urrutia; Liliana Carmona-Aparicio
Journal:  Oxid Med Cell Longev       Date:  2014-08-13       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.